Skip to main content
Therapeutic Advances in Neurological Disorders logoLink to Therapeutic Advances in Neurological Disorders
. 2012 Nov;5(6):375. doi: 10.1177/1756285612463297

Erratum

PMCID: PMC3487535

Abstract

The publisher would like to apologise for an error made in Therapeutic Advances in Neurological Disorders, Volume 5, Issue 5.


In the article: Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity, the author Hans-Peter Hartung should have been acknowledged as one of the corresponding authors.[1].

References

  • [1]. Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung H-P, Kieseier BC, Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity: Ther Adv Neurol Disord 2012, 5(6) 255–266 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Therapeutic Advances in Neurological Disorders are provided here courtesy of SAGE Publications

RESOURCES